Taking this into account, Craig Hallum initiated its SelectQuote Inc [SLQT] rating to a Buy in a research note published on September 30, 2024; the price target was $4.50. A number of analysts have revised their coverage, including Noble Capital Markets’s analysts, who began to cover the stock in late February with a ‘”an Outperform”‘ rating. RBC Capital Mkts maintained its rating on February 08, 2022. It rated SLQT as “a Sector perform”.
Price Performance Review of SLQT
On Friday, SelectQuote Inc [NYSE:SLQT] saw its stock fall -2.67% to $4.38. Over the last five days, the stock has gained 1.62%. SelectQuote Inc shares have risen nearly 17.74% since the year began. Nevertheless, the stocks have risen 294.59% over the past one year. While a 52-week high of $4.64 was reached on 01/24/25, a 52-week low of $1.08 was recorded on 01/02/25. SMA at 50 days reached $3.66, while 200 days put it at $3.01.
Levels Of Support And Resistance For SLQT Stock
The 24-hour chart illustrates a support level at 4.29, which if violated will result in even more drops to 4.19. On the upside, there is a resistance level at 4.51. A further resistance level may holdings at 4.64. The Relative Strength Index (RSI) on the 14-day chart is 58.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.07, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 45.61%. Stochastics %K at 71.31% indicates the stock is a holding.
How much short interest is there in SelectQuote Inc?
A steep rise in short interest was recorded in SelectQuote Inc stocks on 2025-01-15, growing by 0.39 million shares to a total of 2.25 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 1.85 million shares. There was a rise of 17.48%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 08, 2022 when Barclays resumed its ‘”an Equal weight”‘ rating for the stock and retained the price target to $5.
